Phagocytosis-promoting effect of clofazimine (B 663) in patients with subnormal granulocyte function.
D000284:Administration, Oral; D000368:Aged; D002843:Chromatin; D006402:Hematologic Diseases / Q000188:drug therapy; D006801:Humans; D007918:Leprosy / Q000188:drug therapy; D007951:Leukemia, Myeloid / Q000188:drug therapy; D007962:Leukocytes / Q000187:drug effects*; D008297:Male; D009504:Neutrophils; D010587:Phagocytosis / Q000187:drug effects*; D010619:Phenazines / Q000494:pharmacology* / Q000627:therapeutic use; D013997:Time Factors
D002843:Chromatin; D010619:Phenazines